Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03522428
Other study ID # dupin
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date September 15, 2011
Est. completion date December 23, 2012

Study information

Verified date May 2018
Source University of Split, School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pregnancy is associated with increased requirements for iron and increased blood volume of up to 40%. Because expansion in plasma volume is higher than the increase in the mass of red blood cells, there is a fall in hemoglobin concentration, which leads to physiological anemia, characterized with lower hemoglobin (Hb), hematocrit and red blood cells, but without changes in mean corpuscular volume (MCV). Anemia in pregnancy is defined with Hb values under 110 g/L in the first trimester and under 105 g/L in the second and third trimester.

Iron deficiency is thought to be the most common nutrient deficiency among pregnant women. Consequences of anemia include delayed fetal growth, premature delivery, intrauterine fetal death, postpartum depression and delayed psychomotor development of a child. It is known that in women that are not anemic daily iron supplementation of 27 mg/day is sufficient, which can be obtained from adequate nutrition or body supplies. Iron supplementation is pregnancy has been recommended by the WHO (World Health Organisation) since 1959, and this recommendation was confirmed by numerous professional associations. However, in women with anemia, or women subjected to particular dietary regimens with diminished quantity of iron, including vegetarian or vegan diet, required supplementation dosage is higher, and estimated in the literature to be 120 mg/day.

The aim of this study was to analyze whether adding vitamin B12 (5 µg /100 days), along with folic acid and iron as supplement in pregnant women who are not anemic and who need only iron supplementation, will result in improvements of hematological and biochemical markers.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date December 23, 2012
Est. primary completion date December 23, 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- healthy women from 8th week of pregnancy

Exclusion Criteria:

- existence of hypertension

- existence of diabetes

- existence of genetic abnormalities

- smoking

- previous miscarriage

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
vitamin b12
Vitamin B12 has been added to the experimental group of pregnant women, at a dose of 5 µg / 100 days

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mirela Zec

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Red blood cells (RBC) count in first and second trimester RBC count measured in SI (Systeme International) units (Nx10*12/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Hemoglobin (Hgb) concentration in first and second trimester Hgb concentration in SI units (g/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Hematocrit in first and second trimester volume percentage (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Mean corpuscular volume (MCV) in first and second trimester mean volume of red blood cells in SI units (fL) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Mean corpuscular hemoglobin concentration (MCHC) in first and second trimester Average hemoglobin concentration in a given volume of packed RBCs i SI units (g/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Mean corpuscular hemoglobin (MCH) in first and second trimester average weight of hemoglobin in an average red blood cell in SI units (pg) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Iron (Fe) in first and second trimester non-heme iron in serum in SI units (µmol/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Haptoglobin in first and second trimester concentration of free haptoglobin in serum in SI units (g/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Ferritin in first and second trimester serum ferritin in SI units (µg/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Total Iron Binding Capacity (TIBC) in first and second trimester total iron binding capacity in SI units (µmol/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Primary Change of Unsaturated Iron Binding Capacity (UIBC) in first and second trimester unsaturated iron binding capacity in SI units (µmol/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of White Blood Cells (WBC) in first and second trimester RBC count measured in SI units (Nx10*9/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Platelet Count in first and second trimester RBC count measured in SI units (Nx10*9/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Transferrin in first and second trimester transferrin serum concentration in SI units (g/L) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Neutrophils in first and second trimester proportion of neutrophils of all white cells (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Lymphocytes in first and second trimester proportion of lymphocytes of all white cells (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Monocytes in first and second trimester proportion of monocytes of all white cells (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Eosinophils in first and second trimester proportion of eosinophils of all white cells (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
Secondary Change of Basophils in first and second trimester proportion of basophils of all white cells (%) at two time points: on the 8th-10th and 22nd-24th weeks of pregnancy
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06061393 - Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia Phase 4
Recruiting NCT05975125 - The Effect of Vitamin C for Iron Supplementation During Pregnancy With Risk of Anemia N/A
Active, not recruiting NCT05739097 - Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Recruiting NCT03448432 - Prevalence Study of the Etiology of Pregnancy Anemia N/A
Enrolling by invitation NCT04810546 - Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy N/A
Withdrawn NCT03873571 - Adherence of Iron Succinylate Therapy in Pregnancy
Completed NCT04517734 - Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
Recruiting NCT06434870 - Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
Completed NCT04812821 - Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital